193 related articles for article (PubMed ID: 32970810)
1. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia?
Wang W; Thakral B
Blood; 2020 Sep; 136(13):1565. PubMed ID: 32970810
[No Abstract] [Full Text] [Related]
2. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L
JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374
[No Abstract] [Full Text] [Related]
3. Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports.
Lee JM; Kim IS; Lee JN; Park SH; Kim HH; Chang CL; Lee EY; Kim HR; Oh SH; Song SA
Ann Lab Med; 2016 Sep; 36(5):494-7. PubMed ID: 27374717
[No Abstract] [Full Text] [Related]
4. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract][Full Text] [Related]
5. [Plasmacytoid dendritic cell neoplasm in a 71 year-old male].
Centurión MÉ; Navarro JT; Millá F; Feliu E
Med Clin (Barc); 2011 Jul; 137(4):189-90. PubMed ID: 21310442
[No Abstract] [Full Text] [Related]
6. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biologic features of CD4(+)CD56(+) malignancies.
Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
9. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
[TBL] [Abstract][Full Text] [Related]
10. [Hematodermic CD4/CD56 neoplasm].
Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
[TBL] [Abstract][Full Text] [Related]
11. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
[TBL] [Abstract][Full Text] [Related]
12. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
13. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
14. A rare case of acute leukemic presentation of blastic plasmacytoid dendritic cell neoplasm without cutaneous lesions.
Yu S; Kwon MJ; Kim K; Koo DH; Woo HY; Park H
Ann Lab Med; 2014 Mar; 34(2):148-51. PubMed ID: 24624352
[No Abstract] [Full Text] [Related]
15. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
Awasthi NP; Qayoom S; Dabadghao S
J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
[TBL] [Abstract][Full Text] [Related]
17. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
18. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
20. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
